Quarterly report pursuant to Section 13 or 15(d)

INVESTMENTS IN UNCONSOLIDATED ENTITIES - Summary of Condensed Financial Information Related to Unconsolidated Equity Method Joint Ventures, Assets Liabilities and Equity (Details)

v3.23.2
INVESTMENTS IN UNCONSOLIDATED ENTITIES - Summary of Condensed Financial Information Related to Unconsolidated Equity Method Joint Ventures, Assets Liabilities and Equity (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Mar. 31, 2023
Dec. 31, 2022
Mar. 31, 2022
Dec. 31, 2021
Assets                
Real estate $ 4,348,600   $ 4,348,600     $ 4,358,263    
Other assets 1,633,606   1,633,606     1,325,356    
Total assets 6,065,641   6,065,641     5,772,101    
Equity of:                
Meritage 4,248,295 $ 3,412,469 4,248,295 $ 3,412,469 $ 4,067,210 3,949,611 $ 3,168,315 $ 3,044,389
Total liabilities and stockholders’ equity 6,065,641   6,065,641     5,772,101    
(Loss)/earnings from financial services unconsolidated entities and other, net     2,882 2,145        
Unconsolidated entities                
Equity of:                
(Loss)/earnings from financial services unconsolidated entities and other, net 2,611 $ 1,904 3,776 $ 2,870        
Equity Method Investment, Nonconsolidated Investee                
Assets                
Real estate 20,301   20,301     17,965    
Other assets 5,720   5,720     11,653    
Total assets 29,135   29,135     33,007    
Liabilities and equity:                
Accounts payable and other liabilities 5,313   5,313     11,397    
Equity of:                
Meritage [1] 11,637   11,637     10,356    
Other 12,185   12,185     11,254    
Total liabilities and stockholders’ equity 29,135   29,135     33,007    
Cash 3,114   3,114     3,389    
Cash $ 3,114   $ 3,114     $ 3,389    
[1] Balance represents Meritage’s interest, as reflected in the financial records of the respective joint ventures. This balance may differ from the balance reported in the accompanying unaudited consolidated financial statements due to the following reconciling items: (i) timing differences for revenue and distributions recognition, (ii) step-up basis and corresponding amortization, (iii) capitalization of interest on qualified assets, (iv) income deferrals as discussed in Note (2) below and (v) the cessation of allocation of losses from joint ventures in which we have previously written down our investment balance to zero and where we have no commitment to fund additional losses.